NCT04211493

Brief Summary

The study investigates the acute psychological effects of a whole-body-workout using Electromyostimulation (EMS) in participants with depression and healthy individuals.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at below P25 for not_applicable depression

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 22, 2019

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

December 19, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 26, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

August 2, 2021

Status Verified

July 1, 2021

Enrollment Period

2 years

First QC Date

December 19, 2019

Last Update Submit

July 27, 2021

Conditions

Keywords

Physical ActivityPhysical ExerciseMental DisorderDepressionMental HealthHealth BehaviourElectromyostimulationEMSStrength Training

Outcome Measures

Primary Outcomes (1)

  • Change in depressive symptoms

    Depressive symptoms are measured using the State-Scale of the State-Trait Depression Scales (STDS) by Spaderna, Schmukle \& Krohne (2002). The SDTS State-Scale has two subscales with each 5 likert scaled items with values ranging from 1 to 4. Higher scores mean a worse outcome for the first subscale and a better outcome for the second subscale.

    From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session

Secondary Outcomes (4)

  • Change in anxiety symptoms

    From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session

  • Change in general self-efficacy

    From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session

  • Change in intention for physical activity

    From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session

  • Change in self-efficacy regarding physical activity

    From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session

Study Arms (2)

Experimental-Condition

EXPERIMENTAL

20 minutes whole-body-workout with simultaneous muscle stimulation (EMS). Participants carry out easy whole-body-exercises while wearing a EMS-vest-belt-system with interwoven electrodes. During the workout the muscles are simultaneously stimulated by those external electrodes with medium level (5) of stimulation intensity.

Behavioral: whole-body-workoutDevice: EMS

Placebo-Condition

PLACEBO COMPARATOR

20 minutes whole-body-workout without simultaneous muscle stimulation (EMS). Participants carry out easy whole-body-exercises while wearing a EMS-vest-belt-system with interwoven electrodes. During the workout they are stimulated with the lowest possible stimulation intensity (1). This is perceptible as a slight tingling sensation but the impulse intensity lies below the muscular threshold and therefore generates no muscular activity.

Behavioral: whole-body-workoutDevice: EMS-Placebo

Interventions

20 minutes whole-body-workout

Experimental-ConditionPlacebo-Condition
EMSDEVICE

Electromyostimulation-intensity 5 (muscle stimulation)

Experimental-Condition

Electromyostimulation-intensity 1 (no muscle stimulation)

Placebo-Condition

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject familiarized with experimental procedure and had given written informed consent
  • Depression, according to ICD-10
  • BDI-II Score ≥ 14
  • Able to understand German
  • Reachability of participant for the two training sessions

You may not qualify if:

  • Contraindications for physical exercise
  • Contraindications for EMS-use
  • Current EMS-use
  • Pregnancy
  • Borderline personality disorder
  • Bipolar Disorder
  • Schizophrenia
  • Anorexia Nervosa, Bulimia Nervosa
  • Dementia
  • Acute suicidality
  • Substance dependencies with actual consumption (except nicotine)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy

Berlin, 10117, Germany

Location

MeSH Terms

Conditions

DepressionMotor ActivityMental DisordersPsychological Well-Being

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorPersonal Satisfaction

Study Officials

  • Andreas Ströhle, Prof.Dr.

    Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy

    STUDY DIRECTOR
  • Antonia Bendau, M.Sc.Psych.

    Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants are not aware of the study hypothesis.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: The study has a randomised placebo-controlled crossover design. Every participant exercises two training-sessions (experimental-condition, placebo-condition) in randomized order with one week fade-out phase inbetween.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 19, 2019

First Posted

December 26, 2019

Study Start

November 22, 2019

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

August 2, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations